SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Endocrinology Consultation — Johnny Cash — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJohnny Cash
Date of birth1932-02-26
IdentifiersMRN HR-ML004-SYN-TD; SSN (made up) 000-04-8125
Document date2003-03-27
AuthorAyesha Rahimi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Type 2 diabetes above goal in a 71-year-old man with autonomic and peripheral neuropathy and orthostatic hypotension. Please confirm whether diabetic autonomic neuropathy explains his lightheadedness on standing, advise on treating it, and help choose add-on glucose-lowering therapy. [S]

Urgency: Routine, within four weeks; to coincide with his diabetes check. [S]

Questions for the consultant:

History of Present Illness

Mr. Cash is seen at the request of Dr. Hale, on the same day as his four-week diabetes check. Since the first visit he has taken metformin 1000 mg twice daily without stomach upset, and his fasting home glucose readings run 140 to 170 mg/dL, with none below 70 and no shakiness, sweating, or confusion. He stands up in stages, has raised the head of his bed, wears waist-high compression, and drinks about 2 liters a day. He is still lightheaded on standing most mornings and after meals, but he has had no further falls and no fainting. He has no nausea, diarrhea, early fullness, or difficulty passing urine. His feet are numb to the ankles, unchanged. He asks what is causing the lightheadedness. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

1 later historical claim is omitted because it describes events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metformin 500 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with mealsOral route2001-05-06 to 2003-02-27completedS
Metformin 1000 mg oral tablet, one tablet by mouth twice daily with mealsOne tablet by mouth twice daily with mealsOral route2003-02-27activeS
Sitagliptin 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2003-03-27activeS
Atorvastatin 40 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2003-02-27activeS
Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtimeOne drop in each eye at bedtimeOphthalmic route2000-09-11activeS
Dorzolamide 2% ophthalmic solution, one drop in each eye twice dailyOne drop in each eye twice dailyOphthalmic route2003-02-27activeS
Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PMOne tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bedOral route2003-03-27 to 2003-05-29completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intakeactiveconfirmed E11.43S — Synthetic modern diagnosis linked to the publicly reported diabetes and autonomic neuropathy.
Neurogenic orthostatic hypotension from diabetic autonomic neuropathyactiveconfirmed I95.1S — Synthetic finding; explains the autonomic symptoms once labeled Shy-Drager syndrome.
Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feetactiveconfirmed E11.42S — Synthetic finding linked to his description of numb lower extremities.
Primary open-angle glaucoma, both eyes, severe stageactiveconfirmed H40.1133S — Synthetic modern diagnosis; the type and stage are not documented historically.
Mild nonproliferative diabetic retinopathy without macular edema, both eyesactiveconfirmed E11.3293S — Synthetic finding from the dilated eye examination.
Hyperlipidemiaactiveconfirmed E78.5S — Synthetic finding from the baseline LDL cholesterol.
History of recurrent pneumoniaactiveconfirmed Z87.01S — Synthetic modern coding of the documented recurrent pneumonia; supports pneumococcal vaccination.

Physical Exam

Vital signs recorded on 2003-03-27; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralAlert and wry; walks in with a cane
CardiovascularRegular rhythm; blood pressure 150/84 mmHg lying, 142/78 mmHg seated, and 110/68 mmHg after three minutes standing, with heart rate 76 rising only to 80, and lightheadedness
FeetSkin intact; no ulcers or calluses; monofilament and vibration sensation reduced to the ankles; pedal pulses present
NeurologicalReduced ankle reflexes; stocking sensory loss in both legs

Results

DateMeasureValueUnitReference rangeFlagProvenance
2003-03-27Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2003-03-27Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
2003-03-27Creatinine [Mass/volume] in Serum or Plasma1.06mg/dL0.74-1.35 mg/dLNormalS
2003-03-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1998)/1.73 sq M72mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2003-03-27Glucose [Mass/volume] in Serum or Plasma152mg/dL70-99 mg/dLHighS

Assessment

Data reviewed: The intake HbA1c, kidney function, urine albumin-creatinine ratio, vitamin B12, TSH, and hemoglobin; today's basic metabolic panel; the intake and today's lying, seated, and standing blood pressures and heart rates; and his home glucose log. [S]

Plan of Treatment